Our fully automated stainless steel bioreactors are purpose-built for high-density mammalian cell culture, supporting stable production of monoclonal antibodies, recombinant proteins, viral vectors and cell therapy raw materials under strict cGMP standards. Constructed from polished 316L stainless steel with electro-polished internal surfaces, the vessels minimize dead volume, reduce protein adsorption and simplify complete CIP/SIP cycle execution to eliminate cross-contamination risks.
Equipped with a fully integrated automation control system, the bioreactor enables real-time closed-loop regulation of critical culture parameters including temperature, dissolved oxygen, pH, agitation speed, overlay gas flow and feeding strategy. All operational data is automatically recorded with full audit trails to satisfy data integrity requirements for FDA, EMA and PIC/S inspections.
Modular mechanical design delivers flexible scalability from lab-scale seed cultivation to large commercial production volumes. Customized optional configurations include integrated perfusion systems, automated sampling assemblies, sterile nutrient feed manifolds and exhaust condensate treatment units. Every unit complies with ISPE bioprocess engineering specifications, paired with complete DQ/IQ/OQ documentation packages to accelerate facility validation workflows.
Suitable for batch, fed-batch and continuous perfusion mammalian cell workflows, these automated bioreactors deliver consistent cell viability, high product titer and reliable long-run operation, ideal for biopharma and vaccine manufacturers pursuing stable, low-labor biomanufacturing.
